Literature DB >> 25666670

Cohort studies (and skin cancer) never come alone.

Joris A C Verkouteren1, Robert J T van der Leest1, Tamar Nijsten2.   

Abstract

A previous keratinocyte carcinoma is probably the strongest predictor of developing new keratinocyte carcinomas, which makes these patients an interesting population for prevention interventions. Investing in large cohort studies and consortia might increase the validity of observational findings and should stimulate scientists to investigate the underlying mechanisms in detail.

Entities:  

Mesh：

Year:  2015        PMID： 25666670     DOI： 10.1038/jid.2014.482

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  11 in total

1.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

2.  Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group.

Authors:  M R Karagas; T A Stukel; E R Greenberg; J A Baron; L A Mott; R S Stern
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

3.  The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.

Authors:  Robert S Stern
Journal:  J Am Acad Dermatol       Date:  2012-01-20       Impact factor: 11.527

4.  Index event bias as an explanation for the paradoxes of recurrence risk research.

Authors:  Issa J Dahabreh; David M Kent
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

5.  Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Hongmei Nan; Mousheng Xu; Peter Kraft; Abrar A Qureshi; Constance Chen; Qun Guo; Frank B Hu; Gary Curhan; Christopher I Amos; Li-E Wang; Jeffrey E Lee; Qingyi Wei; David J Hunter; Jiali Han
Journal:  Hum Mol Genet       Date:  2011-06-23       Impact factor: 6.150

6.  Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.

Authors:  Ulrike Keim; Jolieke C van der Pols; Gail M Williams; Adèle C Green
Journal:  J Invest Dermatol       Date:  2014-09-18       Impact factor: 8.551

Review 7.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

8.  Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Authors:  Martin A Weinstock; Kachiu C Lee; Mary-Margaret Chren; Kimberly Marcolivio
Journal:  J Am Acad Dermatol       Date:  2009-04-26       Impact factor: 11.527

9.  Skin cancer awareness and sun protection behaviors in white Hispanic and white non-Hispanic high school students in Miami, Florida.

Authors:  Fangchao Ma; Fernando Collado-Mesa; Shasa Hu; Robert S Kirsner
Journal:  Arch Dermatol       Date:  2007-08

10.  Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?

Authors:  M Staples; R Marks; G Giles
Journal:  Int J Cancer       Date:  1998-10-05       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.